CLINICAL_TRIALS
trial_result
· 2019-08-13
Clinical Trial Update: Study of Fruquintinib in Patients With Metastatic Colorectal Cancer [Phase 2]
Summary
Phase 2 clinical trial update for fruquintinib in metastatic colorectal cancer has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hutchison Medipharma Limited | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-08-13